Nat Rev Drug Discov 24 , 631650 (2025)
By Lana Pine | Published on June 19, 2025 4 min read People with diabetes who take glucagon-like peptide-1 (GLP-1) receptor agonists (such as Ozempic and Wegovy) may have more than twice the risk of developing a serious eye condition called neovascular age-related macular degeneration (nAMD) a leading cause of vision loss in older adults according to a large-scale study published in JAMA Ophthalmology
It is important to recognise that pharmaceutical GLP-1 agonists are not cosmetic weight-loss drugs but prescription medications for specific medical conditions
Help managing GLP-1 associated side effects Speak to a health care provider about managing drug side effects and to rule out any other possible causes
Our GLP-1 patch is formulated with berberine, ginger root, and citrus bergamot, ingredients studied to support appetite control and help you stay aligned during your weight loss journey
Keen to share my findings, I made a post in my Facebook group
